Yi Xie

机构：Fujian Medical University, First Affiliated Hospital of Fujian Medical University, Woodlands Health Campus, Nanjing Medical University · ORCID：0000-0001-8095-4856

发表论文 190 篇 · 总被引 5351 次 · h-index 38

代表论文

• Clinical manifestations, antimicrobial resistance and genomic feature analysis of multidrug-resistant Elizabethkingia strains (2024 · Annals of Clinical Microbiology and Antimicrobials · 被引 26)
• Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation (2024 · Neuro-Oncology · 被引 15)
• Serotype, antibiotic susceptibility and whole-genome characterization of Streptococcus pneumoniae in all age groups living in Southwest China during 2018–2022 (2024 · Frontiers in Microbiology · 被引 12)
• Lipocalin-2 regulates astrocyte-oligodendrocyte interaction to drive post-stroke secondary demyelination (2025 · Cell Reports · 被引 11)
• TRPML1 ameliorates seizures-related neuronal injury by regulating autophagy and lysosomal biogenesis via Ca2+/TFEB signaling pathway (2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 被引 10)
• Multicentre evaluation of in vitro activity of contezolid against drug-resistant Staphylococcus and Enterococcus (2024 · Journal of Antimicrobial Chemotherapy · 被引 9)